» Articles » PMID: 10325960

Inhibitors of Poly (ADP-ribose) Synthetase Protect Rat Cardiomyocytes Against Oxidant Stress

Overview
Journal Cardiovasc Res
Date 1999 May 18
PMID 10325960
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Inhibitors of poly (ADP-ribose) synthetase (PARS) activity reduce the infarct size caused by regional myocardial ischaemia and reperfusion in the rabbit and rat in vivo. The mechanism of action of these inhibitors is unclear. Here we investigate the effects of the PARS inhibitor 3-aminobenzamide (3-AB) on infarct size caused by ischaemia and reperfusion of the isolated, perfused heart of the rat. We also investigate the role of PARS in the hydrogen peroxide-mediated cell injury/necrosis in rat cardiac myoblasts.

Methods: Rat isolated hearts perfused at constant pressure (80 mmHg) were subjected to 35 min of regional ischaemia and 2 h of reperfusion. Infarct size was determined at the end of the experiment using nitro-blue tetrazolium. 3-AB (300 microM) or 3-aminobenzoic acid (3-ABA, 300 microM) were infused during the reperfusion period. Rat cardiac myoblasts (H9c2 cells) were preincubated with the PARS inhibitors, 3-AB. nicotinamide (Nic) or 1,5-dihydroxyisoquinoline (ISO) or the inactive analogues 3-ABA or nicotinic acid (NicA) prior to exposure with hydrogen peroxide (1 mM). Cell injury was assessed by measuring mitochondrial respiration and cell necrosis by measuring the release of LDH. PARS activity was determined by measuring the incorporation of NAD into nuclear proteins.

Results: Regional ischaemia and reperfusion of the isolated rat heart resulted in an infarct size of 54% which was reduced by 3-AB, but not by 3-ABA. Exposure of rat cardiac myoblasts to hydrogen peroxide caused an increase in PARS activity and cell injury/necrosis which was attenuated by pretreatment with the PARS inhibitors.

Conclusion: Inhibition of the activity of PARS attenuates the cell death associated with oxidant stress in rat cardiac myoblasts and heart.

Citing Articles

Cardiac contractile dysfunction during acute hyperglycemia due to impairment of SERCA by polyol pathway-mediated oxidative stress.

Tang W, Cheng W, Kravtsov G, Tong X, Hou X, Chung S Am J Physiol Cell Physiol. 2010; 299(3):C643-53.

PMID: 20573996 PMC: 2944313. DOI: 10.1152/ajpcell.00137.2010.


Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.

Pacher P, Szabo C Cardiovasc Drug Rev. 2007; 25(3):235-60.

PMID: 17919258 PMC: 2225457. DOI: 10.1111/j.1527-3466.2007.00018.x.


On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies.

Muscoli C, Cuzzocrea S, Riley D, Zweier J, Thiemermann C, Wang Z Br J Pharmacol. 2003; 140(3):445-60.

PMID: 14522841 PMC: 1574047. DOI: 10.1038/sj.bjp.0705430.


Hsp70 attenuates hypoxia/reoxygenation-induced activation of poly(ADP-ribose) synthetase in the nucleus of adult rat cardiomyocytes.

Tanonaka K, Toga W, Takahashi M, Kawana K, Miyamoto Y, Yoshida H Mol Cell Biochem. 2003; 248(1-2):149-55.

PMID: 12870667 DOI: 10.1023/a:1024192403758.


Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock.

McDonald M, Mota-Filipe H, Wright J, Abdelrahman M, Threadgill M, Thompson A Br J Pharmacol. 2000; 130(4):843-50.

PMID: 10864891 PMC: 1572143. DOI: 10.1038/sj.bjp.0703391.